| Katherine Jane Mcclure, MD | |
|
700 Chief Eddie Hoffman Highway, Bethel, AK 99559-0287 | |
| (907) 543-6300 | |
| (907) 543-6366 |
| Full Name | Katherine Jane Mcclure |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 700 Chief Eddie Hoffman Highway, Bethel, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790806420 | NPI | - | NPPES |
| MD3563 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 3563 (Alaska) | Primary |
| Entity Name | Yukon-kuskokwim Health Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447477815 PECOS PAC ID: 5193718765 Enrollment ID: O20040407001515 |
News Archive
Ipsen, a global biopharmaceutical group, today announced that its partner Roche has disclosed results of the phase III T-emerge 3 study in patients with diabetes with taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence. Taspoglutide originating from Ipsen's research is developed by Roche.
Researchers at the Swedish medical university Karolinska Institutet (KI) have constructed a mathematical activity model of the brain's anterior and superior parts, to increase the understanding of the capacity of the working memory and of how the billions of neurons in the brain interact.
Scientists at A*STAR's Institute of Medical Biology and Institute of Molecular and Cellular Biology have identified a gene encoding a hormone that could potentially be used as a therapeutic molecule to treat heart diseases. The hormone - which they have chosen to name ELABELA - is only 32 amino-acids long, making it amongst the tiniest proteins made by the human body.
DiFusion Incorporated announced today that the company has received a CE Mark and European clearance to market and implant its new CleanFuze antimicrobial orthobiologic polymer. "We are extremely gratified to announce European clearance of our CleanFuze line of antimicrobial spinal implants. This material has been in development for over five years and attaining this milestone represents significant value for our shareholders," commented DiFusion Cofounder and CEO Derrick Johns.
"This week, heads of state, celebrities and CEOs will attend U.N. Secretary General Ban Ki-moon's 'Every Woman, Every Child' dinner in New York," an event that "will highlight the amazing contribution of the Global Fund to Fight AIDS, Tuberculosis and Malaria to the health of women and children in developing countries," Lucy Chesire, executive director and secretary to the board of TB ACTION Group, writes in the Huffington Post's "The Big Push" blog.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Jane Mcclure, MD Po Box 287, Bethel, AK 99559-0287 Ph: (907) 543-6300 | Katherine Jane Mcclure, MD 700 Chief Eddie Hoffman Highway, Bethel, AK 99559-0287 Ph: (907) 543-6300 |
News Archive
Ipsen, a global biopharmaceutical group, today announced that its partner Roche has disclosed results of the phase III T-emerge 3 study in patients with diabetes with taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence. Taspoglutide originating from Ipsen's research is developed by Roche.
Researchers at the Swedish medical university Karolinska Institutet (KI) have constructed a mathematical activity model of the brain's anterior and superior parts, to increase the understanding of the capacity of the working memory and of how the billions of neurons in the brain interact.
Scientists at A*STAR's Institute of Medical Biology and Institute of Molecular and Cellular Biology have identified a gene encoding a hormone that could potentially be used as a therapeutic molecule to treat heart diseases. The hormone - which they have chosen to name ELABELA - is only 32 amino-acids long, making it amongst the tiniest proteins made by the human body.
DiFusion Incorporated announced today that the company has received a CE Mark and European clearance to market and implant its new CleanFuze antimicrobial orthobiologic polymer. "We are extremely gratified to announce European clearance of our CleanFuze line of antimicrobial spinal implants. This material has been in development for over five years and attaining this milestone represents significant value for our shareholders," commented DiFusion Cofounder and CEO Derrick Johns.
"This week, heads of state, celebrities and CEOs will attend U.N. Secretary General Ban Ki-moon's 'Every Woman, Every Child' dinner in New York," an event that "will highlight the amazing contribution of the Global Fund to Fight AIDS, Tuberculosis and Malaria to the health of women and children in developing countries," Lucy Chesire, executive director and secretary to the board of TB ACTION Group, writes in the Huffington Post's "The Big Push" blog.
› Verified 7 days ago
Dr. Mien Chyi, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Chief Eddie Hoffman Hwy, Bethel, AK 99559 Phone: 907-543-6300 | |
Martha Iwamoto, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Yukon-kuskokwim Health Corporation, Yukon-kuskokwim Delta Regional Hospital, Bethel, AK 99559 Phone: 907-543-0000 | |
Dr. Amy Carson-strnad, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Chief Eddie Hoffman Highway, Suite 3000, Bethel, AK 99559 Phone: 907-543-6300 |